Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$17,224,593
in 1 filing
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. EcoR1 Capital, LLC +$17.2M Director 1 filing
  2. RENTON HOLLINGS −$249K Director sold 31% of stake
Date Insider Transaction Shares Price Value Owned after
2017-01-31 Novo A/S 10% owner Purchase +50,000 $15.00 $750K 3,033,504
2017-01-31 Novo A/S 10% owner Conversion · Series B Preferred Stock −1,428,571 0
2017-01-31 Novo A/S 10% owner Conversion · Series C Preferred Stock −486,820 0
2017-01-31 Novo A/S 10% owner Conversion · Series C-1 Preferred Stock −312,986 0
2017-01-31 Novo A/S 10% owner Conversion · Series D Preferred Stock −673,454 0
2017-01-31 Novo A/S 10% owner Option exercise · Series C Preferred Stock Warrant (Right to Buy) −117,235 0
2017-01-31 Topper James N Director Conversion +2,228,377 2,228,377
2017-01-31 Topper James N Director Conversion +733,740 733,740
2017-01-31 Topper James N Director Conversion +209,095 209,095
2017-01-31 Topper James N Director Purchase +311,291 $15.00 $4.7M 1,045,031
2017-01-31 Topper James N Director Purchase +88,709 $15.00 $1.3M 297,804
2017-01-31 Topper James N Director Conversion · Series B Preferred Stock −1,428,571 0
2017-01-31 Topper James N Director Conversion · Series C Preferred Stock −604,055 0
2017-01-31 Topper James N Director Conversion · Series C-1 Preferred Stock −195,751 0
2017-01-31 Topper James N Director Conversion · Series D Preferred Stock −733,740 0
2017-01-31 Topper James N Director Conversion · Series D Preferred Stock −209,095 0
2017-01-31 Gallagher Carol Giltner Director Conversion +64,296 64,296
2017-01-31 Gallagher Carol Giltner Director Conversion · Series C Preferred Stock −42,857 0
2017-01-31 Gallagher Carol Giltner Director Conversion · Series D Preferred Stock −21,439 0
2017-01-31 Lydon Nicholas Director Conversion +203,625 270,957

Page 34 of 36 · 714 trades